Exosome Therapy + PRP (Platelet-Rich Plasma)
Documented synergy between Exosome Therapy and PRP (Platelet-Rich Plasma). Canonical combination in literature · see protocol and evidence.
View comparison →Extracellular vesicles for regeneration and cellular communication
Definition and how it works: Exosomes are extracellular vesicles of 30–150 nm secreted by virtually every cell in the body, carrying mRNA, microRNA, proteins and lipids between cells. They act as intercellular messengers that modulate inflammation, stimulate regeneration and coordinate immune responses. In longevity medicine, exosomes derived from mesenchymal stem cells (MSCs) are used for their potent regenerative and anti-inflammatory paracrine effects.
Exosomes are extracellular vesicles of 30–150 nm secreted by virtually every cell in the body, carrying mRNA, microRNA, proteins and lipids between cells. They act as intercellular messengers that modulate inflammation, stimulate regeneration and coordinate immune responses. In longevity medicine, exosomes derived from mesenchymal stem cells (MSCs) are used for their potent regenerative and anti-inflammatory paracrine effects.
Origin and history
Exosomes were discovered by Rose Johnstone in 1987, initially considered 'cellular waste'. Their function as intercellular messengers was established in the 2000s. The therapeutic application of MSC exosomes began to be investigated from 2010 and entered cutting-edge clinics around 2018.
1. Assessment and goals Definition of indication (hair, joint, facial, systemic) and route of administration.
2. Product preparation Thawing of GMP exosome vial. Verification of viability and concentration (>5×10⁹ particles/ml).
3. Administration IV (systemic), intradermal (skin/hair), intra-articular (joints) or intranasal.
4. Post-treatment Avoid anti-inflammatories for 48 hours (they inhibit the regenerative response). Adequate hydration.
5. Follow-up Hair photography or arthroscopy at 3 months. Repeat based on response.
| Equipment | Brand / Model | Technical detail |
|---|---|---|
| GMP MSC exosome product | ExoFlo (Direct Biologics) / Kimera Labs | Bone marrow MSC-derived exosomes. >10⁹ particles/ml. GMP certification. |
| Nanoparticle analysis chamber | NanoSight NS300 / ZetaView | Characterisation of exosome size, concentration and zeta potential. |
Clinics on LongevityMap declare their exact equipment for objective scoring.
Extracellular vesicles for regeneration and cellular communication
€300–1,500 per session (varies by route and concentration)
1–3 sessions (4–6 weeks apart)
Prices vary by clinic, equipment and practitioner experience. LongevityMap compares price and quality so you always make the best decision.
Documented synergy between Exosome Therapy and PRP (Platelet-Rich Plasma). Canonical combination in literature · see protocol and evidence.
View comparison →Documented synergy between Exosome Therapy and Stem Cell Therapy. Canonical combination in literature · see protocol and evidence.
View comparison →Documented synergy between Exosome Therapy and HIFU & Radiofrequency. Canonical combination in literature · see protocol and evidence.
View comparison →We are collecting signed consents under GDPR Art. 9.2.a. First verified testimonials will appear once the first real clinics are onboarded (Q4 2026).
MSC-derived exosomes contain over 10,000 identified proteins and 2,000 miRNAs. Studies in Stem Cell Research & Therapy show that MSC exosomes reproduce most of the therapeutic effects of MSCs themselves without the risks of cell transplantation. Research on alopecia with MSC exosomes published in the International Journal of Molecular Sciences shows 30–40% increases in hair density at 3 months.
Pharmaceutics 2026 SR: MSC-derived exosomes are a promising cell-free nanotherapeutic strategy for cardiac repair after MI and ischemia/reperfusion. Modulate cardiomyocyte apoptosis, inflammation, mitochondrial function, oxidative stress and angiogenesis. Predominantly preclinical evidence.
Stem Cell Reviews 2026: review on MSC, exosomes and bioengineered scaffolds for osteoarthritis and rheumatoid arthritis. Regenerative strategies beyond symptomatic treatment, with immunomodulatory and paracrine effects for cartilage restoration.
Aesthetic Surgery Journal 2026: comparative study of umbilical cord (UC)- vs adipose-derived (AD) MSC exosomes in human skin. Biologically distinct but clinically convergent in their effects on skin.
2026 rat study (androgenic alopecia model): hypoxia-conditioned MSC exosomes (EH-MSC) modulate cytokines: ↑ GM-CSF (regenerative effect) and ↓ IL-1α (anti-inflammatory) dose-dependent. Minoxidil did NOT reduce IL-1α. Preclinical evidence.
Last bibliographic review: 2026-03-28.
In principle, yes, because they are acellular particles that cannot replicate or differentiate. The risk of rejection or tumour formation is theoretically lower. However, the regulation and standardisation of exosome products is still developing.
Depending on the goal: IV (systemic effects), intradermal (skin and hair), intra-articular (joints) or intranasal (brain effects). Each route requires specific protocols and concentrations.
Exosomes are classified as advanced therapy medicinal products in the EU, regulated by the EMA. Clinics using them must hold specific AEMPS authorisation. It is essential to verify the provenance and GMP certification of the product.
Tell us your goal and budget. We cross-reference 500+ clinical parameters and generate 3 personalised plans with Exosome Therapy.
Generate My Protocol for freeLongevityMap content is for informational and educational purposes only. It does not constitute personalised medical advice. Always consult a healthcare professional before starting any treatment. Our team · Methodology